Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma

[1] Rogers HW(2015)Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population, 2012 JAMA Dermatol 151 1081-1086

[2] Weinstock MA(2016)The economics of skin cancer: an analysis of Medicare payment data Plast Reconstr Surg Glob Open 4 574-597

[3] Feldman SR(2016)Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 14 540-559

[4] Coldiron BM(2018)Guidelines of care for the management of basal cell carcinoma J Am Acad Dermatol 78 531-550

[5] Chen JT(2012)AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American academy of dermatology, American college of Mohs surgery, American Society for dermatologic surgery association, and the American society for Mohs surgery J Am Acad Dermatol 67 1039-1045

[6] Kempton SJ(2006)Treatment of basal cell carcinoma with curettage alone J Am Acad Dermatol 54 91-95

[7] Rao VK(2007)Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation J Am Acad Dermatol 56 496-503

[8] Bichakjian CK(1983)Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma J Am Acad Dermatol 8 569-578

[9] Olencki T(2002)The current status of curettage and electrodesiccation Dermatol Clin 20 579-587

[10] Aasi SZ(2007)Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma Dermatol Surg 33 547-553

[1] Rogers HW(2015)Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population, 2012 JAMA Dermatol 151 1081-1086

[2] Weinstock MA(2016)The economics of skin cancer: an analysis of Medicare payment data Plast Reconstr Surg Glob Open 4 574-597

[3] Feldman SR(2016)Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 14 540-559

[4] Coldiron BM(2018)Guidelines of care for the management of basal cell carcinoma J Am Acad Dermatol 78 531-550

[5] Chen JT(2012)AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American academy of dermatology, American college of Mohs surgery, American Society for dermatologic surgery association, and the American society for Mohs surgery J Am Acad Dermatol 67 1039-1045

[6] Kempton SJ(2006)Treatment of basal cell carcinoma with curettage alone J Am Acad Dermatol 54 91-95

[7] Rao VK(2007)Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation J Am Acad Dermatol 56 496-503

[8] Bichakjian CK(1983)Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma J Am Acad Dermatol 8 569-578

[9] Olencki T(2002)The current status of curettage and electrodesiccation Dermatol Clin 20 579-587

[10] Aasi SZ(2007)Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma Dermatol Surg 33 547-553